Chenodeoxycholic Acid

Especificaciones

474-25-9Número CAS

207-481-8Número CE

(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acidNombre IUPAC

C24H40O4Fórmula química

392.6 g/molPeso molecular

chenodeoxycholic acid; Chenodiol; 474-25-9; Chenix; Cdca; Chenic acid; Chenodesoxycholic acid; Chendol; Gallodesoxycholic acid; Anthropodeoxycholic acid; Anthropodesoxycholic acid; Anthropododesoxycholic acid; Fluibil; Chenocol; Chenossil; Cholanorm; Xenbilox; 3alpha,7alpha-Dihydroxy-5beta-cholan-24-oic acid; Henohol; 3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Chenique Acid; Acidum chenodeoxycholicum; CTEXLI; 7alpha-hydroxylithocholic acid; Chenocedon; DTXSID2020260; 0GEI24LG0J; acido quenodeoxicolico; (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; acide chenodesoxycholique; NSC-657949; NSC-757798; DTXCID40260; CHEBI:16755; Acid, Chenic; Chenodal; Chenophalk; Combidol; Lithofalk; Acid, Chenique; (4R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentanoic acid; Chendol 125; Chendol 250; Acid, Chenodeoxycholic; acido chenodesossicolico; Acid, Gallodesoxycholic; RefChem:57540; Chenodeoxycholate, Sodium; chAnodAsoxycholique (acide); A05AA01; 207-481-8; Chenofalk; Chenodesoxycholsaeure; Chenodiol [USAN]; Chenocholic acid; Acido chenodeoxicholico; Chenodesoxycholsaeure [German]; Acide chenodeoxycholique; 7-alpha-Hydroxylithocholic acid; MFCD00064142; (3alpha,5beta,7alpha)-3,7-dihydroxycholan-24-oic acid; Acide chenodeoxycholique [INN-French]; Acido chenodeoxicholico [INN-Spanish]; Acidum chenodeoxycholicum [INN-Latin]; 3-alpha,7-alpha-Dihydroxycholanic acid; 3-alpha,7-alpha-Dihydroxycholansaeure [German]; 3-alpha,7-alpha-Dihydroxycholansaeure; Chenodeoxycholic acid [INN]; 3-alpha,7-alpha-Dihydroxy-5-beta-cholan-24-oic acid; Chenodiol (USAN); (R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy-; 3a,7a-dihydroxy-5b-cholan-24-oic acid; (3alpha,5beta,7alpha,8xi)-3,7-dihydroxycholan-24-oic acid; Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7alpha)-; Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)-; Chenodex; Chenodeoxycholicacid; (4R)-4-((1S,2S,7S,11S,5R,9R,10R,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo [8.7.0.0<2,7>.0<11,15>]heptadec-14-yl)pentanoic acid; Chendeoxycholic Acid; CCRIS 2195; 24404-86-2; (3|A,5|A,7|A)-3,7-Dihydroxycholan-24-oic Acid; EINECS 207-481-8; UNII-0GEI24LG0J; NSC 657949; Chendal; Chenorm; Hekbilin; Kebilis; Chenodeoxycholic acid; 3a,7a-dihydroxy-5ss-cholan-24-oic acid; NSC657949; NCGC00016387-02; Ursodeoxycholic Acid EP Impurity A; CAS-474-25-9; CDCA (Standard); JN3; chenodeoxycholic-acid; Cholan-24-oic acid, 3,7-dihydroxy-, (3a,5b,7a)-; (+)-chenodeoxycholate; CHENODIOL [MI]; Prestwick0_000285; Prestwick1_000285; Prestwick2_000285; Prestwick3_000285; Spectrum5_002009; CHENIX (TN); Chenodeoxycholic acid CRS; CHENODIOL [VANDF]; (+)-chenodeoxycholic acid; bmse000908; 7a-Hydroxy-desoxycholsaeure; EC 207-481-8; BIDD:PXR0056; SCHEMBL25055; BSPBio_000190; GTPL608; MLS002154253; 3a,7a-dihydroxy-5b-cholanate; SPBio_002409; BPBio1_000210; CHEMBL240597; Chenodeoxycholic acid, >=97%; orb3139782; CHENODIOL [ORANGE BOOK]; Chenodeoxycholic acid (Standard); 7.alpha.-Hydroxylithocholic acid; BDBM21674; 3a,7a-dihydroxy-5b-cholanic acid; HMS1568J12; HMS2095J12; HMS2234I22; HMS3712J12; Chenodeoxycholic acid (JP16/INN); Chenodeoxycholic acid (JP18/INN); CHENODEOXYCHOLIC ACID [JAN]; MSK10387; Tox21_110412; Tox21_200491; US10208081, CDCA; (3beta,7beta,8xi,9xi,14xi,17alpha)-3,7-dihydroxycholan-24-oic acid; 3a,7a-dihydroxy-5b-cholan-24-oate; Cholan-24-oic acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.alpha.)-; EBC-11080; HSCI1_000210; LMST04010032; SBB002935; CHENODEOXYCHOLIC ACID [MART.]; AKOS024280614; CHENODEOXYCHOLIC ACID [WHO-DD]; CCG-220285; CS-0834; DB06777; FC09675; 5beta-Cholanic acid-3alpha,7alpha-diol; SMP1_000064; 3.alpha.,7.alpha.-Dihydroxycholansaeure; 3a,7a-dihydroxy-5b,14a,17b-cholanate; NCGC00142400-03; NCGC00142400-04; NCGC00142400-08; NCGC00142400-15; NCGC00258045-01; (4R)-4-[(1R,3aS,3bR,4R,5aS,7R,9aS,9bS,11aR)-4,7-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]pentanoic acid; 3.alpha.,7.alpha.-Dihydroxycholanic acid; AS-13636; HY-76847; SMR000857194; ST033520; SY075777; CHENODEOXYCHOLIC ACID [EP IMPURITY]; CHENODEOXYCHOLIC ACID [EP MONOGRAPH]; 3a,7a-dihydroxy-5b,14a,17b-cholanic acid; AB00513822; NS00069558; (3a,5b,7a)-3,7-dihydroxy-cholan-24-oate; 3alpha, 7alpha-dihydroxy-5beta-cholanoic acid; EN300-75328; 3alpha, 7alpha,-dihydroxy-5beta-cholanic acid; C-2900; C02528; D00163; (3a,5b,7a)-3,7-dihydroxy-cholan-24-oic acid; AB00513822-06; AB00513822_07; Chenodeoxycholic acid for peak identification CRS; Chenodeoxycholic acid for system suitability CRS; F218990; Q419028; 3.alpha.,7.alpha.-Dihydroxy-5.beta.-cholanic acid; Dihydroxy-3.alpha.,7.alpha.(5.beta.)Cholanic acid; Leadiant (formerly Chenodeoxycholic acid sigma-tau); (3|_,5|_,7|_)-3,7-Dihydroxycholan-24-oic acid; 3.alpha.,7.alpha.-Dihydroxy-5.beta.-cholanoic acid; BRD-K18135438-001-14-2; BRD-K18135438-001-16-7; URSODEOXYCHOLIC ACID IMPURITY A [EP IMPURITY]; 0DBBBC66-0CFA-4DB9-97F4-5B1492756A02; Z1172235745; 3.alpha.,7.alpha.-Dihydroxy-5.beta.-cholan-24-oic acid; Ursodeoxycholic Acid EP Impurity A ; Chenodeoxycholic Acid; 5.beta.-Cholan-24-oic acid, 3.alpha.,7.alpha.-dihydroxy-; (3alpha,5alpha,7beta,8alpha,17alpha)-3,7-dihydroxycholan-24-oic acid; 3,7-Dihydroxycholan-24-oic acid, (3.alpha.,5.beta.,7.alpha.)- #; Chenodeoxycholic acid, 500 mug/mL in methanol, certified reference material; Chenodeoxycholic acid, European Pharmacopoeia (EP) Reference Standard; Cholan-24-oic acid, 3,7-dihydroxy-, (3-.alpha., 5-.beta., 7-.alpha.)-; Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)- (9CI); CHOLAN-24-OIC ACID, 3,7-DIHYDROXY-, (3.ALPHA.,5.BETA.,7.ALPHA.); (4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0?,?.0??,??]heptadecan-14-yl]pentanoic acid; (4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid; (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoicacidSinónimos